More Topics:
PSS World Medical Proposes Offering of $250M Notes
Posted February 10, 2012
We Recommend...
JACKSONVILLE, Fla., -- PSS World Medical, Inc. (Nasdaq:PSSI) announced today its intention to offer, subject to market and other conditions, approximately $250 million aggregate principal amount of senior notes due 2022. The company intends to use a portion of the net proceeds from the offering to repay borrowings under its new credit facility and to partially pre-fund the repayment of its 3.125% convertible notes due 2014 and for general corporate purposes, including potential repurchases of common stock and acquisitions.
The notes are being offered inside the United States to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act.
The notes have not been registered under the Securities Act or applicable state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This announcement does not constitute an offer to sell or the solicitation of an offer to buy the notes.
About PSS World Medical
PSS World Medical, Inc. markets and distributes medical products to physicians, elder care providers and alternate-site healthcare providers throughout the United States. Since its inception in 1983, PSS has become a leader in the market segments that it serves with a focused approach to customer service and operational excellence. The Company's stated purpose is to strengthen the clinical success and financial health of caregivers by solving their biggest problems.
blog comments powered by